CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention
| Status: | Recruiting |
|---|---|
| Conditions: | Psychiatric |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/28/2019 |
| Start Date: | October 1, 2018 |
| End Date: | January 31, 2021 |
| Contact: | Research Team |
| Email: | research@ebpi.org |
| Phone: | 206-455-7934 |
This Phase II study is a continuation of the Phase I feasibility study where the
investigators fully met and exceeded project aims to design, build, and test the usability
and acceptability of an avatar-based system, the Virtual-CAMS (V-CAMS, formerly called
CAMS-RAS), for use by suicidal ED patients and medical personnel responsible for their care.
Phase II includes a formative phase, during which the investigators will continue conducting
usability and acceptability tests of new features, and a summative phase to conduct a
clinical trial. SBIR Phase II project aims include: (1) Complete development of V-CAMS,
including readiness for electronic health record integration; (2) Cultivate and utilize the
advisory board so that V-CAMS is positioned to meet the needs of diverse healthcare systems
and successful conduct of the proposed research; (3) Conduct usability/acceptability tests of
new features with target end-users (suicidal patients, including those in the ED, medical
providers) and key stakeholders (i.e., administrators); and (4) Conduct a randomized
controlled trial (RCT; N=90) of suicidal ED patients comparing V-CAMS (n=45) to Care-As-Usual
(CAU; n=45). Participants will be assessed at baseline while in the ED, and again at 7, 30,
and 90 days. The investigators predict that V-CAMS participants will report a significantly
greater decrease in suicidal behaviors and ED/hospital admissions, as well as significantly
greater increases in use of behavioral coping skills, self-efficacy in coping with distress,
and perceived helpfulness of patients' ED experience.
investigators fully met and exceeded project aims to design, build, and test the usability
and acceptability of an avatar-based system, the Virtual-CAMS (V-CAMS, formerly called
CAMS-RAS), for use by suicidal ED patients and medical personnel responsible for their care.
Phase II includes a formative phase, during which the investigators will continue conducting
usability and acceptability tests of new features, and a summative phase to conduct a
clinical trial. SBIR Phase II project aims include: (1) Complete development of V-CAMS,
including readiness for electronic health record integration; (2) Cultivate and utilize the
advisory board so that V-CAMS is positioned to meet the needs of diverse healthcare systems
and successful conduct of the proposed research; (3) Conduct usability/acceptability tests of
new features with target end-users (suicidal patients, including those in the ED, medical
providers) and key stakeholders (i.e., administrators); and (4) Conduct a randomized
controlled trial (RCT; N=90) of suicidal ED patients comparing V-CAMS (n=45) to Care-As-Usual
(CAU; n=45). Participants will be assessed at baseline while in the ED, and again at 7, 30,
and 90 days. The investigators predict that V-CAMS participants will report a significantly
greater decrease in suicidal behaviors and ED/hospital admissions, as well as significantly
greater increases in use of behavioral coping skills, self-efficacy in coping with distress,
and perceived helpfulness of patients' ED experience.
Inclusion Criteria:
- 18 years or older
- English speaker
- Clinically stable Suicidal Patient* currently admitted to the ED, psychiatric
inpatient unit, and medical floors of the participating sites; Suicidal Patients
currently receiving outpatient mental health services
- Hospital medical personnel who treat suicidal patients, hospital administrators,
hospital-based peer advocates, and outpatient mental health clinicians and
administrators
"Suicidal Patient" is defined as those patients who:
1. Have explicitly indicated to their treatment provider that they are suicidal and/or
are seeking treatment in part because they want to kill themselves or
2. Have made a suicide attempt in the last six months or
3. Engaged in non-suicidal self-injurious behaviors with high suicidal ideation (defined
as 4 to 5 on a 0-5 point Likert scale) in the past three months.
"Clinically Stable"and not in clear and imminent danger is defined as:
1. Patients who are oriented to time, place, person and are no longer in acute phase of
distress that led to their ED admission (for those in the ED)
2. For those in outpatient context, patient is not in imminent risk for suicide as deemed
by their treatment provider
3. In all cases, patient is able to follow instructions for mood improvement/distress
tolerance protocol to help stabilize their mood; current status is unlikely to worsen
as a result of engagement with research staff in study activities as deemed by their
treatment provider.
The Site Contact or Coordinators and/or designated medical staff will determine if suicidal
patients fit these criteria before referring them to the research team.
Exclusion Criteria:
- Acutely psychotic and thus unable to provide informed consent
- Severely agitated (as deemed by physician, nurse, or outpatient therapist)
- Not fluent in English
We found this trial at
1
site
Click here to add this to my saved trials
